The combo trial is paid and done, its in the history books. We are only waiting to learn how fantastic the end results are. You don't need a CFO for that.
The point I'm making is that if you're a young and vibrant biotech, with a vision for the next stage of your company and (near future) approved biotech product and a vision for your next big medical trial you desperately need a CFO to prepare for the tens if not hundreds of millions to finance your next big medical trial and the selling and marketing of your approved product. There is zero indication NWBO is remotely interested in dong so.
Market Data 
Markets 
AI
